Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Short SellingSee which listed companies have disclosed short interest
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Aino Health subsidiary signs agreement with HUS-Group for work ability management software

AINORegulatory press release05.11.2026 klo 18.35
Download the release

Aino Health AB (publ) announces that its subsidiary Aino Health Management Oy has signed an agreement with HUS-Group following its selection as supplier in a public procurement for a work ability management software solution.
HUS-Group is Finland’s largest healthcare provider and is responsible for organising specialised healthcare in the Uusimaa region.

The agreement covers the delivery and implementation of the software, integrations, maintenance and support services. The solution is intended to support HUS’s work ability management processes, including early support, sickness absence management, identification of work ability risks, return-to-work support, reporting and analysis.

Based on the tendered prices and an assumed user population of 26,500, Aino Health estimates the value of the agreement during the initial 24-month fixed term at approximately EUR 520,000 excluding VAT. This estimate includes the software service, implementation and currently estimated additional work. Actual revenue may differ depending on the number of users and additional services ordered. The estimate does not include any period after the initial 24-month term.

The agreement is initially valid for a fixed term of 24 months that starts today and will continue until further notice thereafter. During the indefinite term, HUS’s notice period is six months and Aino Health Management Oy’s notice period is 12 months. Notice may be given during the fixed term, but the agreement cannot terminate before the end of that term.

This information is information that Aino Health is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2026-11-05 17:35 CET.

For more information
Jyrki Eklund, CEO Aino Health
Phone: +358 40 042 4221
Email: jyrki.eklund@ainohealth.com

Aino Health AB (publ) is listed on Nasdaq Stockholm First North Growth Market (Ticker: AINO).

Certified Adviser
Tapper Partners AB
More info: https://investors.ainohealth.com/certified-adviser/

About Aino Health (publ)
Aino Health is the leading provider of Software as a Service (SaaS) solutions for Corporate Health Management. Our platform helps organizations reduce sickness absences, identify root causes of health challenges, and systematize proactive support for employees. For more information, please visit ainohealth.com.

Attachments
Aino Health subsidiary signs agreement with HUS-Group for work ability management software